 | • レポートコード：MRC2303J0026 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、252ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：バイオ |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートによると、2021年に7,481.35百万ドルであった世界の細胞分離技術市場規模は、2022年に8,870.64百万ドルになり、2027年までにCAGR 18.62％で拡大して20,848.86百万ドルに達するとみられています。本書は、細胞分離技術の世界市場を対象とした調査結果をまとめたものであり、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、技術別（ろ過分離、勾配遠心分離、表面マーカー分離）分析、製品別（消耗品、機器）分析、用途別（がん研究、免疫研究、神経科学研究、幹細胞研究）分析、エンドユーザー別（バイオテクノロジー＆製薬会社、細胞バンク、病院＆診断研究所）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報など、下記の項目を掲載しています。なお、本書内の企業情報としては、10x Genomics、Akadeum Life Sciences、BD Biosciences、Bio-Rad Laboratories, Inc、Bio-Techne、Life Technologies Corporation、Merck Millipore、Miltenyi Biotec GmbH、PerkinElmer, Inc.、PluriSelect GmbH、QIAGEN、STEMCELL Technologies, Inc.、Terumo BCT, Inc.、Zeissなどが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の細胞分離技術市場規模：技術別 - ろ過分離技術の市場規模 - 勾配遠心分離技術の市場規模 - 表面マーカー分離技術の市場規模 ・世界の細胞分離技術市場規模：製品別 - 消耗品の市場規模 - 機器の市場規模 ・世界の細胞分離技術市場規模：用途別 - がん研究における市場規模 - 免疫研究における市場規模 - 神経科学研究における市場規模 - 幹細胞研究における市場規模 ・世界の細胞分離技術市場規模：エンドユーザー別 - バイオテクノロジー＆製薬会社における市場規模 - 細胞バンクにおける市場規模 - 病院＆診断研究所における市場規模 ・世界の細胞分離技術市場規模：地域別 - 南北アメリカの細胞分離技術市場規模 アメリカの細胞分離技術市場規模 カナダの細胞分離技術市場規模 ブラジルの細胞分離技術市場規模 ... - アジア太平洋の細胞分離技術市場規模 日本の細胞分離技術市場規模 中国の細胞分離技術市場規模 インドの細胞分離技術市場規模 韓国の細胞分離技術市場規模 台湾の細胞分離技術市場規模 ... - ヨーロッパ/中東/アフリカの細胞分離技術市場規模 イギリスの細胞分離技術市場規模 ドイツの細胞分離技術市場規模 フランスの細胞分離技術市場規模 ロシアの細胞分離技術市場規模 ... - その他地域の細胞分離技術市場規模 ・競争状況 ・企業情報 |
The Global Cell Separation Technologies Market size was estimated at USD 7,481.35 million in 2021 and expected to reach USD 8,870.64 million in 2022, and is projected to grow at a CAGR 18.62% to reach USD 20,848.86 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Cell Separation Technologies to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Technology, the market was studied across Filtration Based Separation, Gradient Centrifugation, and Surface Markers Separation. The Surface Markers Separation is further studied across .Magnetic Cell Sorting and Fluorescence-Activated Cell Sorting.
Based on Product, the market was studied across Consumables and Instruments. The Consumables is further studied across Beads, Disposables, and Reagents, Kits, Media, and Sera. The Instruments is further studied across Centrifuges, Filtration Systems, Flow Cytometers, and Magnetic-activated Cell Separator Systems.
Based on Application, the market was studied across Cancer Research, Immunology, Neuroscience Research, and Stem Cell Research.
Based on End User, the market was studied across Biotechnology and Pharmaceutical Companies, Cell Banks, and Hospitals and Diagnostic Laboratories.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Cell Separation Technologies market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cell Separation Technologies Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Cell Separation Technologies Market, including 10x Genomics, Akadeum Life Sciences, BD Biosciences, Bio-Rad Laboratories, Inc, Bio-Techne, Life Technologies Corporation, Merck Millipore, Miltenyi Biotec GmbH, PerkinElmer, Inc., PluriSelect GmbH, QIAGEN, STEMCELL Technologies, Inc., Terumo BCT, Inc., and Zeiss.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Cell Separation Technologies Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell Separation Technologies Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell Separation Technologies Market?
4. What is the competitive strategic window for opportunities in the Global Cell Separation Technologies Market?
5. What are the technology trends and regulatory frameworks in the Global Cell Separation Technologies Market?
6. What is the market share of the leading vendors in the Global Cell Separation Technologies Market?
7. What modes and strategic moves are considered suitable for entering the Global Cell Separation Technologies Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising cases of chronic diseases and neurodegenerative diseases
5.1.1.2. Increasing developments in the biotechnology industry
5.1.1.3. Rapidly growing health care infrastructures
5.1.2. Restraints
5.1.2.1. Cost related to the cell-based research is high
5.1.3. Opportunities
5.1.3.1. Growing government fundings in the life science area and in separation technologies
5.1.3.2. Ongoing research and development in the cell therapy
5.1.4. Challenges
5.1.4.1. Strict rules and regulations of the government
5.2. Cumulative Impact of COVID-19
6. Cell Separation Technologies Market, by Technology
6.1. Introduction
6.2. Filtration Based Separation
6.3. Gradient Centrifugation
6.4. Surface Markers Separation
6.5.1. .Magnetic Cell Sorting
6.5.2. Fluorescence-Activated Cell Sorting
7. Cell Separation Technologies Market, by Product
7.1. Introduction
7.2. Consumables
7.3.1. Beads
7.3.2. Disposables
7.3.3. Reagents, Kits, Media, and Sera
7.3. Instruments
7.4.1. Centrifuges
7.4.2. Filtration Systems
7.4.3. Flow Cytometers
7.4.4. Magnetic-activated Cell Separator Systems
8. Cell Separation Technologies Market, by Application
8.1. Introduction
8.2. Cancer Research
8.3. Immunology
8.4. Neuroscience Research
8.5. Stem Cell Research
9. Cell Separation Technologies Market, by End User
9.1. Introduction
9.2. Biotechnology and Pharmaceutical Companies
9.3. Cell Banks
9.4. Hospitals and Diagnostic Laboratories
10. Americas Cell Separation Technologies Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cell Separation Technologies Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Cell Separation Technologies Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. 10x Genomics
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Akadeum Life Sciences
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. BD Biosciences
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Bio-Rad Laboratories, Inc
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Bio-Techne
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Life Technologies Corporation
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Merck Millipore
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Miltenyi Biotec GmbH
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. PerkinElmer, Inc.
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. PluriSelect GmbH
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. QIAGEN
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. STEMCELL Technologies, Inc.
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Terumo BCT, Inc.
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Zeiss
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing